Inhibition of bcl-2 Enhances the Efficacy of Chemotherapy in Renal Cell Carcinoma
- 14 December 2004
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 47 (5), 703-709
- https://doi.org/10.1016/j.eururo.2004.11.013
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen)Clinical Cancer Research, 2004
- Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patientsBritish Journal of Cancer, 2004
- The future of antisense therapy: combination with anticancer treatmentsOncogene, 2003
- Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID MiceAntisense and Nucleic Acid Drug Development, 2002
- Antitumor Effect ofbcl-2Antisense Phosphorothioate Oligodeoxynucleotides on Human Renal-Cell Carcinoma Cellsin Vitroand in MiceMolecular Urology, 2001
- Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic OriginsJNCI Journal of the National Cancer Institute, 2001
- The Hallmarks of CancerCell, 2000
- Mitochondria and ApoptosisScience, 1998
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Influence on Stability inEscherichia coliof the Carboxy-Terminal Structure of Cloned Moloney Murine Leukemia Virus Reverse TranscriptaseDNA, 1986